BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 19169242)

  • 1. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia.
    Zhao C; Chen A; Jamieson CH; Fereshteh M; Abrahamsson A; Blum J; Kwon HY; Kim J; Chute JP; Rizzieri D; Munchhof M; VanArsdale T; Beachy PA; Reya T
    Nature; 2009 Apr; 458(7239):776-9. PubMed ID: 19169242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation.
    Dierks C; Beigi R; Guo GR; Zirlik K; Stegert MR; Manley P; Trussell C; Schmitt-Graeff A; Landwerlin K; Veelken H; Warmuth M
    Cancer Cell; 2008 Sep; 14(3):238-49. PubMed ID: 18772113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells.
    Babashah S; Sadeghizadeh M; Hajifathali A; Tavirani MR; Zomorod MS; Ghadiani M; Soleimani M
    Int J Cancer; 2013 Aug; 133(3):579-89. PubMed ID: 23341351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status.
    Cea M; Cagnetta A; Cirmena G; Garuti A; Rocco I; Palermo C; Pierri I; Reverberi D; Nencioni A; Ballestrero A; Gobbi M; Carella AM; Patrone F
    Leuk Lymphoma; 2013 Feb; 54(2):342-52. PubMed ID: 22762548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia.
    Irvine DA; Zhang B; Kinstrie R; Tarafdar A; Morrison H; Campbell VL; Moka HA; Ho Y; Nixon C; Manley PW; Wheadon H; Goodlad JR; Holyoake TL; Bhatia R; Copland M
    Sci Rep; 2016 May; 6():25476. PubMed ID: 27157927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Acylguanidine Derivatives Targeting Smoothened Induce Antiproliferative and Pro-Apoptotic Effects in Chronic Myeloid Leukemia Cells.
    Chiarenza A; Manetti F; Petricci E; Ruat M; Naldini A; Taddei M; Carraro F
    PLoS One; 2016; 11(3):e0149919. PubMed ID: 26934052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Hedgehog pathway in chronic myelogeneous leukemia patients.
    Long B; Zhu H; Zhu C; Liu T; Meng W
    J Exp Clin Cancer Res; 2011 Jan; 30(1):8. PubMed ID: 21235817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The controversial role of the Hedgehog pathway in normal and malignant hematopoiesis.
    Mar BG; Amakye D; Aifantis I; Buonamici S
    Leukemia; 2011 Nov; 25(11):1665-73. PubMed ID: 21660044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hedgehog pathway activation in chronic myeloid leukemia.
    Jagani Z; Dorsch M; Warmuth M
    Cell Cycle; 2010 Sep; 9(17):3449-56. PubMed ID: 20928937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cancer stem cells in chronic myeloid leukaemia.
    Jørgensen HG; Holyoake TL
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1347-51. PubMed ID: 17956348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
    Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
    J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
    Aljedai A; Buckle AM; Hiwarkar P; Syed F
    PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
    Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
    Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
    Galperin I; Dempwolff L; Diederich WE; Lauth M
    J Med Chem; 2019 Sep; 62(18):8392-8411. PubMed ID: 30986059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exovesicular-Shh confers Imatinib resistance by upregulating Bcl2 expression in chronic myeloid leukemia with variant chromosomes.
    Anusha ; Dalal H; Subramanian S; V P S; Gowda DA; H K; Damodar S; Vyas N
    Cell Death Dis; 2021 Mar; 12(3):259. PubMed ID: 33707419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for allosteric interactions of antagonist binding to the smoothened receptor.
    Rominger CM; Bee WL; Copeland RA; Davenport EA; Gilmartin A; Gontarek R; Hornberger KR; Kallal LA; Lai Z; Lawrie K; Lu Q; McMillan L; Truong M; Tummino PJ; Turunen B; Will M; Zuercher WJ; Rominger DH
    J Pharmacol Exp Ther; 2009 Jun; 329(3):995-1005. PubMed ID: 19304771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2.
    Abe Y; Oda-Sato E; Tobiume K; Kawauchi K; Taya Y; Okamoto K; Oren M; Tanaka N
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4838-43. PubMed ID: 18359851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.